Congjun Xu
Impact in
-
- Nanoparticle-Based Drug Delivery
-
- Nanoplatforms for cancer theranostics
Papers in
-
- Protein Degradation and Inhibitors 2
- Epigenetics and DNA Methylation 2
- Co-authors
- Chunshun Zhao (7 shared papers)Yanjuan Huang (6 shared papers)Liang‐Feng Huang (2 shared papers)Gaofei Wei (2 shared papers)Yifeng Shen (3 shared papers)Xiaoyu Xu (4 shared papers)Zeqian Huang (3 shared papers)Zishan Zeng (3 shared papers)
- Journals
- European Journal of Medicinal Chemistry (4 papers)Journal of Medicinal Chemistry (4 papers)Phytochemistry (2 papers)Drug Delivery (1 paper)Advanced Healthcare Materials (1 paper)
- Partner nations
- China
In The Last Decade
Congjun Xu
23 papers receiving 426 citations
Peers
Comparison fields: 5 of 61
- Biomaterials 61
- Biomedical Engineering 180
- Oncology 77
- Immunology 61
- Pulmonary and Respiratory Medicine 86
Countries citing papers authored by Congjun Xu
This map shows the geographic impact of Congjun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Congjun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Congjun Xu more than expected).
Fields of papers citing papers by Congjun Xu
This network shows the impact of papers produced by Congjun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Congjun Xu. The network helps show where Congjun Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Congjun Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 83 | |
| 2 | 2019 | 68 | |
| 3 | 2021 | 50 | |
| 4 | 2022 | 46 | |
| 5 | 2021 | 43 | |
| 6 | 2019 | 22 | |
| 7 | 2023 | 17 | |
| 8 | 2017 | 13 | |
| 9 | 2022 | 12 | |
| 10 | 2024 | 10 | |
| 11 | 2025 | 9 | |
| 12 | 2021 | 7 | |
| 13 | 2024 | 7 | |
| 14 | 2021 | 6 | |
| 15 | 2017 | 6 | |
| 16 | 2024 | 5 | |
| 17 | 2017 | 5 | |
| 18 | 2024 | 5 | |
| 19 | 2024 | 5 | |
| 20 | 2025 | 4 |
About Congjun Xu
Congjun Xu is a scholar working on Molecular Biology, Organic Chemistry, Biomedical Engineering, Pharmacology and Immunology, having authored 25 papers that have together received 429 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (7 papers), Nanoparticle-Based Drug Delivery (3 papers), Marine Sponges and Natural Products (3 papers), Ferroptosis and cancer prognosis (2 papers), Protein Degradation and Inhibitors (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Biomaterials (61 citations), Biomedical Engineering (180 citations), Oncology (77 citations), Immunology (61 citations) and Pulmonary and Respiratory Medicine (86 citations). Congjun Xu has collaborated with scholars based in China. Frequent co-authors include Chunshun Zhao, Yanjuan Huang, Liang‐Feng Huang, Gaofei Wei, Yifeng Shen, Xiaoyu Xu, Zeqian Huang, Zishan Zeng, Zilin Guan and Yali Jiang. Their work appears in journals such as European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, Phytochemistry, Drug Delivery and Advanced Healthcare Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.